Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Hemophagocytic Lymphohistiocytosis (HLH) Gene Panel is typically 10-14 days after the sample is received by the testing laboratory.

What are the prerequisites for the test Hemophagocytic Lymphohistiocytosis (HLH) Gene Panel

  • Patient must have clinical signs and symptoms consistent with Hemophagocytic Lymphohistiocytosis (HLH)
  • Physician's order
  • Signed informed consent by patient or legal guardian
  • Blood sample

What are the measure values for the test Hemophagocytic Lymphohistiocytosis (HLH) Gene Panel

  • PRF1 Gene
    • Normal Range: 0-1.5 copies
  • UNC13D Gene
    • Normal Range: 0-1.5 copies
  • STX11 Gene
    • Normal Range: 0-1.5 copies
  • STXBP2 Gene
    • Normal Range: 0-1.5 copies

What does this test Hemophagocytic Lymphohistiocytosis (HLH) Gene Panel identify?

  • Hemophagocytic Lymphohistiocytosis (HLH) Gene Panel identifies mutations in genes associated with HLH, a rare and life-threatening immune disorder characterized by uncontrolled activation of T cells and macrophages.
  • Specifically, the panel tests for mutations in genes such as PRF1, UNC13D, STX11, STXBP2, SH2D1A, and others that are known to be involved in the regulation of immune response and cytotoxic activity.
  • Identifying mutations in these genes can help confirm a diagnosis of HLH and guide treatment decisions, as certain genetic mutations may have implications for prognosis and response to therapy.

Why is this test Hemophagocytic Lymphohistiocytosis (HLH) Gene Panel taken?

The Hemophagocytic Lymphohistiocytosis (HLH) Gene Panel test is taken to diagnose and monitor individuals suspected of having HLH, a rare and life-threatening condition characterized by an overactive immune response. This test looks for mutations in genes associated with HLH, such as PRF1, UNC13D, STX11, STXBP2, and others. Identifying these mutations can help confirm a diagnosis of HLH and guide treatment decisions. The test may be recommended for individuals with symptoms of HLH, such as fever, enlarged liver or spleen, low blood cell counts, and abnormal blood clotting. It may also be used in families with a history of HLH to identify carriers of the gene mutations.

No FAQs available.

Customer Google Rating